Grant: CIHR Fellowship
University of Toronto
$135,000.00
High-throughput screen for protein inhibitors of CRISPR-Cas systems: discovery and mechanistic categorization
FY 2016-17
Summary
CRISPR-Cas, a recently discovered gene-editing technology, is a game-changer. Not only is it more precise than previously developed gene-editing tools, but it is also cheaper, faster, and easier to use. These qualities have made CRISPR-Cas extremely attractive to researchers around the world and across a wide range of specialties. As a result, this gene-editing technology has been quickly adopted for use in biological, agricultural, veterinary, and medical research to create, for example, hardier crops and new cancer treatments. The lab where I will be conducting my research was the first in the world to discover anti-CRISPR proteins, which stop CRISPR-Cas from functioning. They were also the first to figure out how some anti-CRISPR proteins perform this important task. I will be continuing this work by asking key questions, such as: "What do anti-CRISPR proteins look like?", "Are they common and widespread?", "Do anti-CRISPR proteins carry out their work in different ways?", "Is stopping CRISPR-Cas from functioning their only job?", and "Can I design a computer program that will quickly and accurately categorize new anti-CRISPR proteins based on their predicted functions or structures?" In the laboratory, I will perform a high-throughput screen to look for binding partners (potential anti-CRISPR proteins) to the Cas proteins. In the office, I will write a computer program to interpret the laboratory results and to use information from other research groups to categorize and summarize our current knowledge of all known anti-CRISPR proteins. This work should provide us with a better understanding of how anti-CRISPR proteins work to stop CRISPR-Cas from functioning and anything else they might be doing. The results of my study may also lead to the use of anti-CRISPR proteins in combination with CRISPR-Cas as tools for biomedical research.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
362053
Name
Trost Chantel N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Not applicable / Specified
Prcname2
Fellowships - Post-PhD
Projecttitle
High-throughput screen for protein inhibitors of CRISPR-Cas systems: discovery and mechanistic categorization
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Anti-Crispr Proteins; Bacterial Two-Hybrid; Bioinformatics; Crispr-Cas; Genomic Dna Libraries; High-Throughput Functional Screen; Mechanisms Of Inhibition And Modulation; Protein-Protein Interactions; Type I-F
Abstract
CRISPR-Cas, a recently discovered gene-editing technology, is a game-changer. Not only is it more precise than previously developed gene-editing tools, but it is also cheaper, faster, and easier to use. These qualities have made CRISPR-Cas extremely attractive to researchers around the world and across a wide range of specialties. As a result, this gene-editing technology has been quickly adopted for use in biological, agricultural, veterinary, and medical research to create, for example, hardier crops and new cancer treatments. The lab where I will be conducting my research was the first in the world to discover anti-CRISPR proteins, which stop CRISPR-Cas from functioning. They were also the first to figure out how some anti-CRISPR proteins perform this important task. I will be continuing this work by asking key questions, such as: "What do anti-CRISPR proteins look like?", "Are they common and widespread?", "Do anti-CRISPR proteins carry out their work in different ways?", "Is stopping CRISPR-Cas from functioning their only job?", and "Can I design a computer program that will quickly and accurately categorize new anti-CRISPR proteins based on their predicted functions or structures?" In the laboratory, I will perform a high-throughput screen to look for binding partners (potential anti-CRISPR proteins) to the Cas proteins. In the office, I will write a computer program to interpret the laboratory results and to use information from other research groups to categorize and summarize our current knowledge of all known anti-CRISPR proteins. This work should provide us with a better understanding of how anti-CRISPR proteins work to stop CRISPR-Cas from functioning and anything else they might be doing. The results of my study may also lead to the use of anti-CRISPR proteins in combination with CRISPR-Cas as tools for biomedical research.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Trost, Chantel N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~